868 related articles for article (PubMed ID: 16428481)
21. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
[TBL] [Abstract][Full Text] [Related]
22. Long-term prognostic value of conventional peritoneal lavage cytology in patients undergoing curative colorectal cancer resection.
Noura S; Ohue M; Seki Y; Yano M; Ishikawa O; Kameyama M
Dis Colon Rectum; 2009 Jul; 52(7):1312-20. PubMed ID: 19571710
[TBL] [Abstract][Full Text] [Related]
23. Lack of prognostic influence of circulating tumor cells in peripheral blood of patients with colorectal cancer.
Bessa X; Elizalde JI; Boix L; Piñol V; Lacy AM; Saló J; Piqué JM; Castells A
Gastroenterology; 2001 Apr; 120(5):1084-92. PubMed ID: 11266372
[TBL] [Abstract][Full Text] [Related]
24. Rapid genetic diagnosis with the transcription-reverse transcription concerted reaction system for cancer micrometastasis.
Ishii T; Fujiwara Y; Ohnaka S; Hayashi T; Taniguchi H; Takiguchi S; Yasuda T; Yano M; Monden M
Ann Surg Oncol; 2004 Aug; 11(8):778-85. PubMed ID: 15289240
[TBL] [Abstract][Full Text] [Related]
25. Detection of occult metastasis in lymph nodes from colorectal cancer patients: a multiple-marker reverse transcriptase-polymerase chain reaction study.
Chen G; McIver CM; Texler M; Lloyd JM; Rieger N; Hewett PJ; Sen Wan D; Hardingham JE
Dis Colon Rectum; 2004 May; 47(5):679-86. PubMed ID: 15037935
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of reverse transcriptase-polymerase chain reaction measurement of carcinoembryonic antigen mRNA levels in tumor drainage blood and peripheral blood of patients with colorectal carcinoma.
Taniguchi T; Makino M; Suzuki K; Kaibara N
Cancer; 2000 Sep; 89(5):970-6. PubMed ID: 10964326
[TBL] [Abstract][Full Text] [Related]
27. Identification of patients with high-risk stage II colon cancer for adjuvant therapy.
Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Landmann RG; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
Dis Colon Rectum; 2008 May; 51(5):503-7. PubMed ID: 18322753
[TBL] [Abstract][Full Text] [Related]
28. Identification of patients with high-risk for pulmonary metastases after curative resection of colorectal cancer.
Anannamcharoen S; Boonya-Ussadol C
J Med Assoc Thai; 2012 May; 95 Suppl 5():S86-91. PubMed ID: 22934451
[TBL] [Abstract][Full Text] [Related]
29. Persistent evidence of circulating tumor cells detected by means of RT-PCR for CEA mRNA predicts early relapse: a prospective study in node-negative breast cancer.
Jotsuka T; Okumura Y; Nakano S; Nitta H; Sato T; Miyachi M; Suzumura K; Yamashita J
Surgery; 2004 Apr; 135(4):419-26. PubMed ID: 15041966
[TBL] [Abstract][Full Text] [Related]
30. [Cytokeratin 20 as a marker of tumor progression or dissemination in patients with colorectal cancer].
Garrido S M; Ramírez V P; Risueño A C; Orellana U E; Galindo A H; Alvarez Z M
Rev Med Chil; 2008 Apr; 136(4):482-90. PubMed ID: 18769791
[TBL] [Abstract][Full Text] [Related]
31. Value of reverse transcription polymerase chain assay in peripheral blood of patients with urothelial cancer.
Okegawa T; Kinjo M; Nutahara K; Higashihara E
J Urol; 2004 Apr; 171(4):1461-6. PubMed ID: 15017198
[TBL] [Abstract][Full Text] [Related]
32. Presence of minute cancer cell dissemination in peritoneal lavage fluid detected by reverse transcription PCR is an independent prognostic factor in patients with resectable pancreatic cancer.
Eguchi H; Ohigashi H; Takahashi H; Yano M; Motoori M; Miyashiro I; Kishi K; Ohue M; Noura S; Seki Y; Yamada T; Goto K; Yamamoto T; Idota A; Fujii J; Nakajima H; Yamasaki T; Ishikawa O
Surgery; 2009 Nov; 146(5):888-95. PubMed ID: 19744431
[TBL] [Abstract][Full Text] [Related]
33. Clinical evaluation of a panel of mRNA markers in the detection of disseminated tumor cells in patients with operable breast cancer.
Varangot M; Barrios E; Sóñora C; Aizen B; Pressa C; Estrugo R; Lavigna R; Musé I; Osinaga E; Berois N
Oncol Rep; 2005 Aug; 14(2):537-45. PubMed ID: 16012742
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
[TBL] [Abstract][Full Text] [Related]
35. Expression of annexin a5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas.
Xue G; Hao LQ; Ding FX; Mei Q; Huang JJ; Fu CG; Yan HL; Sun SH
J Clin Gastroenterol; 2009 Oct; 43(9):831-7. PubMed ID: 19461527
[TBL] [Abstract][Full Text] [Related]
36. Prospective study of the quantitative carcinoembryonic antigen and cytokeratin 20 mRNA detection in peritoneal washes to predict peritoneal recurrence in gastric carcinoma patients.
Tamura N; Iinuma H; Takada T
Oncol Rep; 2007 Mar; 17(3):667-72. PubMed ID: 17273749
[TBL] [Abstract][Full Text] [Related]
37. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of intraperitoneal cancer cells in gastric carcinoma: analysis of real time reverse transcriptase-polymerase chain reaction after 5 years of followup.
Kodera Y; Nakanishi H; Ito S; Mochizuki Y; Ohashi N; Yamamura Y; Fujiwara M; Koike M; Tatematsu M; Nakao A
J Am Coll Surg; 2006 Feb; 202(2):231-6. PubMed ID: 16427547
[TBL] [Abstract][Full Text] [Related]
39. Tumor volume and tumor marker index based on CYFRA 21-1 and CEA are strong prognostic factors in operated early stage NSCLC.
Muley T; Fetz TH; Dienemann H; Hoffmann H; Herth FJ; Meister M; Ebert W
Lung Cancer; 2008 Jun; 60(3):408-15. PubMed ID: 18083270
[TBL] [Abstract][Full Text] [Related]
40. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
